ReviewEuropean journal of anaesthesiology and intensive care2026
Perioperative considerations for patients with multiple myeloma.
Review in European journal of anaesthesiology and intensive care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple myeloma is an incurable cancer characterised by clonal plasma-cell proliferation, arising predominantly in the bone marrow but producing widespread systemic complications. Additionally, this cancer usually presents in elderly patients who are often frail and suffering from multiple comorbidities. The global prevalence of multiple myeloma is steadily increasing, with therapeutic advances contributing to improved survival. There are several complications of multiple myeloma that the anaesthetist needs to be aware of arising from the disease itself, specific and supportive treatments adverse effects, as well as underlying patient complexities. The preoperative period demands a comprehensive, systematic assessment that identifies and optimises disease- and treatment-related complications, quantifies frailty, addresses anaemia through patient blood management principles, and stratifies thrombotic risk. Intraoperative management requires careful individualisation of anaesthetic technique in the absence of multiple myeloma-specific evidence-based guidelines, with particular vigilance directed at airway complexity, haemodynamic instability, heightened bleeding risk, and challenging pain management. Postoperative care must sustain these principles, with early attention to renal function, pain control, thromboprophylaxis, and the prompt recognition of the infectious complications to which this population is disproportionately vulnerable. Unfortunately, the literature on anaesthesia in the context of multiple myeloma is sparse, largely limited to isolated case reports. As a consequence, this article's predominantly PubMed-based search strategy (included in supplementary materials) required a wide search to allow for perioperative recommendations that are necessarily extrapolated from broader oncological, haematological, and surgical evidence. As such, this article offers a comprehensive review of anaesthetic considerations in multiple myeloma, addressing an important gap in current practice guidance.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.